Clinical Trial Update: Influence of Aliskiren on Proteinuria [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the influence of aliskiren on proteinuria in patients with chronic kidney disease and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension
• Proteinuria

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Chronic Kidney Disease, Proteinuria | Phase 4 | Status: COMPLETED